SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-050392
Filing Date
2013-02-12
Accepted
2013-02-12 09:01:18
Documents
10
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d451190d10q.htm 10-Q 235128
2 EX-31.1 d451190dex311.htm EX-31.1 9727
3 EX-31.2 d451190dex312.htm EX-31.2 9719
4 EX-32.1 d451190dex321.htm EX-32.1 4992
  Complete submission text file 0001193125-13-050392.txt   2169221

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT meip-20121231.xml EX-101.INS 185778
6 XBRL TAXONOMY EXTENSION SCHEMA meip-20121231.xsd EX-101.SCH 28703
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20121231_cal.xml EX-101.CAL 26542
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20121231_def.xml EX-101.DEF 157461
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20121231_lab.xml EX-101.LAB 244123
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20121231_pre.xml EX-101.PRE 182478
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 13594526
SIC: 2834 Pharmaceutical Preparations